QQQ   423.11 (-0.64%)
AAPL   166.76 (-0.74%)
MSFT   405.10 (-1.64%)
META   502.30 (+1.65%)
GOOGL   155.96 (+0.32%)
AMZN   178.91 (-1.31%)
TSLA   150.16 (-3.40%)
NVDA   844.72 (+0.52%)
AMD   154.32 (+0.19%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.23 (+0.68%)
F   12.00 (-0.33%)
MU   112.58 (-3.22%)
GE   153.59 (-1.34%)
CGC   8.15 (+25.58%)
DIS   112.80 (-0.12%)
AMC   2.91 (-2.35%)
PFE   25.31 (-0.43%)
PYPL   62.09 (-1.85%)
XOM   118.17 (-0.39%)
QQQ   423.11 (-0.64%)
AAPL   166.76 (-0.74%)
MSFT   405.10 (-1.64%)
META   502.30 (+1.65%)
GOOGL   155.96 (+0.32%)
AMZN   178.91 (-1.31%)
TSLA   150.16 (-3.40%)
NVDA   844.72 (+0.52%)
AMD   154.32 (+0.19%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.23 (+0.68%)
F   12.00 (-0.33%)
MU   112.58 (-3.22%)
GE   153.59 (-1.34%)
CGC   8.15 (+25.58%)
DIS   112.80 (-0.12%)
AMC   2.91 (-2.35%)
PFE   25.31 (-0.43%)
PYPL   62.09 (-1.85%)
XOM   118.17 (-0.39%)
QQQ   423.11 (-0.64%)
AAPL   166.76 (-0.74%)
MSFT   405.10 (-1.64%)
META   502.30 (+1.65%)
GOOGL   155.96 (+0.32%)
AMZN   178.91 (-1.31%)
TSLA   150.16 (-3.40%)
NVDA   844.72 (+0.52%)
AMD   154.32 (+0.19%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.23 (+0.68%)
F   12.00 (-0.33%)
MU   112.58 (-3.22%)
GE   153.59 (-1.34%)
CGC   8.15 (+25.58%)
DIS   112.80 (-0.12%)
AMC   2.91 (-2.35%)
PFE   25.31 (-0.43%)
PYPL   62.09 (-1.85%)
XOM   118.17 (-0.39%)
QQQ   423.11 (-0.64%)
AAPL   166.76 (-0.74%)
MSFT   405.10 (-1.64%)
META   502.30 (+1.65%)
GOOGL   155.96 (+0.32%)
AMZN   178.91 (-1.31%)
TSLA   150.16 (-3.40%)
NVDA   844.72 (+0.52%)
AMD   154.32 (+0.19%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.23 (+0.68%)
F   12.00 (-0.33%)
MU   112.58 (-3.22%)
GE   153.59 (-1.34%)
CGC   8.15 (+25.58%)
DIS   112.80 (-0.12%)
AMC   2.91 (-2.35%)
PFE   25.31 (-0.43%)
PYPL   62.09 (-1.85%)
XOM   118.17 (-0.39%)

BioMarin Pharmaceutical (BMRN) News Today

$90.05
-0.42 (-0.46%)
(As of 02:40 PM ET)
SourceHeadline
marketbeat.com logoLeerink Partnrs Analysts Lower Earnings Estimates for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - April 18 at 6:48 AM
marketbeat.com logoInternational Assets Investment Management LLC Invests $3.60 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - April 18 at 4:36 AM
finance.yahoo.com logoBioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - April 17 at 2:20 PM
MarketBeat logoBioMarin Pharmaceutical (BMRN) Set to Announce Earnings on Wednesday
americanbankingnews.com - April 17 at 2:50 AM
investing.com logoBiomarin CEO sells over $3.6m in company stock
investing.com - April 17 at 12:55 AM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Sells 50,979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - April 16 at 5:04 AM
insidertrades.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Jean Jacques Bienaime Sells 20,000 Shares
insidertrades.com - April 16 at 4:18 AM
marketbeat.com logoInsider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells 20,000 Shares of Stock
marketbeat.com - April 15 at 6:47 PM
MarketBeat logoErin Burkhart Sells 2,286 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock
americanbankingnews.com - April 14 at 4:42 AM
MarketBeat logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Recommendation of "Moderate Buy" by Brokerages
americanbankingnews.com - April 14 at 2:12 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - April 14 at 2:11 AM
ca.investing.com logoMerck, Vertex could beat expectations despite more subdued 1Q biopharma earnings anticipated: BofA
ca.investing.com - April 13 at 7:43 AM
insidertrades.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CAO Erin Burkhart Sells 2,286 Shares
insidertrades.com - April 13 at 7:09 AM
finance.yahoo.com logoInsider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
finance.yahoo.com - April 12 at 9:01 PM
prnewswire.com logoBioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
prnewswire.com - April 10 at 8:00 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Assenagon Asset Management S.A.
marketbeat.com - April 5 at 4:35 AM
marketbeat.com logoChina Universal Asset Management Co. Ltd. Has $2.14 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - April 4 at 6:54 PM
insidertrades.com logoInsider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells 24,602 Shares of Stock
insidertrades.com - April 2 at 4:10 AM
finance.yahoo.com logoInsider Sell: EVP, Chief Legal Officer George Davis Sells 24,602 Shares of Biomarin ...
finance.yahoo.com - April 1 at 8:53 PM
marketbeat.com logoAMI Asset Management Corp Sells 86,669 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 30 at 11:21 PM
marketbeat.com logoFort Washington Investment Advisors Inc. OH Sells 142,656 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 25 at 2:13 PM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - March 20 at 3:40 AM
marketbeat.com logoVanguard Group Inc. Lowers Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 19 at 5:17 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Down 6.1% in February
marketbeat.com - March 18 at 10:54 AM
insidertrades.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells $85,510.00 in Stock
insidertrades.com - March 17 at 8:34 AM
insidertrades.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Insider Henry J. Fuchs Sells 35,341 Shares
insidertrades.com - March 17 at 6:50 AM
stocknews.com logo3 B-Rated Biotech Stocks to Boost Your Bottom Line
stocknews.com - March 15 at 10:12 AM
finance.yahoo.com logoBMRN May 2024 90.000 call
finance.yahoo.com - March 15 at 5:30 AM
marketbeat.com logoDNB Asset Management AS Sells 111,156 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 14 at 10:49 AM
marketbeat.com logoBraun Stacey Associates Inc. Sells 177,727 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 12 at 9:33 AM
prnewswire.com logoNew Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
prnewswire.com - March 12 at 8:30 AM
finance.yahoo.com logoBioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growth
finance.yahoo.com - March 11 at 1:46 PM
marketbeat.com logoSeven Eight Capital LP Has $235,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 11 at 7:11 AM
marketbeat.com logoAQR Capital Management LLC Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 10 at 5:55 AM
finance.yahoo.com logoInsider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...
finance.yahoo.com - March 8 at 3:06 AM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Andlauer Healthcare Group (OtherANDHF)
markets.businessinsider.com - March 7 at 12:04 PM
prnewswire.com logoBioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
prnewswire.com - March 7 at 8:30 AM
prnewswire.com logoBioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
prnewswire.com - March 7 at 8:30 AM
marketbeat.com logoQube Research & Technologies Ltd Sells 407,530 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 5 at 8:24 AM
marketbeat.com logoEULAV Asset Management Has $11.68 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 4 at 11:17 AM
marketbeat.com logoCalifornia State Teachers Retirement System Sells 13,173 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 3 at 7:32 AM
marketbeat.com logoEnvestnet Asset Management Inc. Has $11.13 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - March 2 at 5:11 AM
markets.businessinsider.com logoBuy Rating Justified by BioMarin’s Strategic R&D and Voxzogo’s Market Potential
markets.businessinsider.com - March 1 at 5:50 PM
prnewswire.com logoBioMarin Scheduled to Participate in March Investor Conferences
prnewswire.com - March 1 at 9:00 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Fmr LLC
marketbeat.com - March 1 at 5:00 AM
marketbeat.com logoSherbrooke Park Advisers LLC Invests $1.11 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
marketbeat.com - February 29 at 10:01 AM
marketbeat.com logoFY2024 Earnings Estimate for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Issued By Cantor Fitzgerald
marketbeat.com - February 29 at 8:53 AM
seekingalpha.com logoBioMarin Pharmaceutical: Still Has A Lot Of Room For Growth
seekingalpha.com - February 29 at 12:39 AM
marketbeat.com logoBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by DSC Advisors L.P.
marketbeat.com - February 28 at 4:20 PM
bizjournals.com logoJustice Department targets another Bay Area drug maker's sponsored testing program
bizjournals.com - February 27 at 2:32 PM
Get BioMarin Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter.

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad)

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

BMRN Media Mentions By Week

BMRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMRN
News Sentiment

0.50

0.49

Average
Medical
News Sentiment

BMRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMRN Articles
This Week

17

6

BMRN Articles
Average Week

Get BioMarin Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BMRN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners